MedPath

Assessment of the effect of sublingual isosorbide dinitrate with indomethacin suppository on post Endoscopic retrograde colangiopancreatography pancreatitis

Phase 3
Conditions
pancreatitis.
Idiopathic acute pancreatitis
Registration Number
IRCT138810082931N1
Lead Sponsor
Digestive disease research center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Study populations are all patients referred to Shariati hospital who undergo therapeutic or diagnostic ERCP in endoscopy ward.
Exclusion criteria: age<18; HX of nitrate use; HX of recent acute pancreatitis (less than one month); HX of chronic pancreatitis; recent (2weeks) peptic ulcer bleeding; HX of glaucoma; ampullary tumor; use of sildenafil; unwilling for consent; allergy to drugs; previous sphincterotomy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post ercp pancratitis. Timepoint: 24 hours after ercp. Method of measurement: pain observative scale, serum amylase measurement, hospitalation period.
Secondary Outcome Measures
NameTimeMethod
ausea and vomiting. Timepoint: 24 hours after procedure. Method of measurement: asking from patient.;Fever/chills. Timepoint: 2 and 24 hours after procedure. Method of measurement: check of fever grade with termometer.;Upper GI bleeding. Timepoint: 2 and 24 hours after procedure. Method of measurement: check of vital sighns, hematemesis and melena.
© Copyright 2025. All Rights Reserved by MedPath